UNIMED (UMED)
UNIMED UMED
Health care · compartment A
Performance
Computed from Tunis Stock Exchange quotations (817 sessions since 15/05/2023). annualised volatility 20.9% · beta 0.52 · maximum drawdown -16.4% · 52 weeks: 7.960 – 10.950
Block trades
1 block trade(s) declared since 13/04/2026 — off-book, gap to the session close.
| Date | Quantity | Price | Volume MTND | Gap |
|---|---|---|---|---|
| 13/04/2026 | 1,122,600 | 10.000 | 11.23 | +11.1 % |
Financial ratios
Computed in-house from the financial statements for the year ended 31/12/2024, extracted from the PDF filed on the Tunis Stock Exchange website. Amounts in millions of dinars.
| Size and earnings | ||
|---|---|---|
| Shareholders' equitybalance sheet total | 112.7 M | |
| Net income | 18.5 M | |
| Total assets | 212.7 M | |
| EBITDA | 16.7 M | |
| Per share | ||
| Earnings per sharenet income / listed shares | 0.577 | |
| Book value per share | 3.523 | |
| Dividend per sharefinancial year 2024 | 0.570 | |
| Valuation | ||
| P/Eprice / earnings per share | 17.5 | — |
| Price / book value | 2.87 | — |
| Enterprise value / EBITDA | 18.3 | |
| Returns and payout | ||
| Return on equity | 16.4 % | — |
| Return on assets | 8.7 % | |
| Dividend yieldat today's price | 5.64 % | — |
| Payout ratiodividends / net income | 99 % | |
No median is published for this sector: fewer than five constituents carry the ratio.
Composite score
59.9 / 100 — rank 20 of 75, on 8 available factors. Each factor is a percentile rank within the market; the score is their weighted average (method and weights). An observational ranking, not investment advice.
Filings
18 archived document(s); the 20 most recent. Links to the Tunis Stock Exchange PDFs.
- 22/072026UNITE DE FABRICATION DE MEDICAMENTS - Indicateurs d'activité trimestriels du 30/06/2026
- 29/052026UNITE DE FABRICATION DE MEDICAMENTS - Assemblée Générale Ordinaire du 17/06/2026
- 21/052026UNITE DE FABRICATION DE MEDICAMENTS - Etats Financiers Annuels Consolidés du 31/12/2025
- 20/052026UNITE DE FABRICATION DE MEDICAMENTS - Avis et communiqués - Appel à candidature
- 14/052026UNITE DE FABRICATION DE MEDICAMENTS - Avis et communiqués - Communiqué de presse
- 05/092025UNIMED - Etats financiers semestriels au 30/06/2025
- 08/072025UNIMED - Etats financiers annuels individuels au 31/12/2024
- 08/072025UNIMED - Etats financiers annuels consolidés au 31/12/2024
- 20/092024UNIMED - Etats financiers semestriels au 30/06/2024
- 20/062024UNIMED - Etats financiers annuels individuels au 31/12/2023
- 20/062024UNIMED - Etats financiers annuels consolidés au 31/12/2023
- 02/102023UNIMED - Etats financiers semestriels au 30/06/2023
- 04/052023UNIMED - Etats financiers annuels au 31/12/2022
- 13/092022UNIMED - Etats financiers semestriels au 30/06/2022
- 14/062022UNIMED - Etats financiers annuels au 31/12/2021
- 21/092021UNIMED - Etats financiers semestriels au 30/06/2021
- 20/052021UNIMED - Etats financiers annuels au 31/12/2020
- 04/092020UNIMED - Etats financiers semestriels au 30/06/2020